Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 209 articles: HTML format Text format

Single Articles

January 2012
1. DONATO MF , Galmozzi E, Rigamonti C, Aghemo A, et al
   Post-liver transplantantion graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients.
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. VILLANUEVA A , Forns X, Llovet JM
   Molecular epidemiology in HCV-related hepatocellular carcinoma: first steps.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. THU THUY PT , Bunchorntavakul C, Tan Dat H, Rajender Reddy K, et al
   A Randomized Trial of 48 versus 24 Weeks of Combination Pegylated Interferon and Ribavirin Therapy in Genotype 6 Chronic Hepatitis C.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GUEDJ J , Dahari H, Pohl RT, Ferenci P, et al
   Understanding silibinin's modes of action against HCV using viral kinetic modeling.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. VALENTI L , Aghemo A, Stattermayer AF
   Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients.
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
6. TREPO E , Pradat P, McCarthy J, Tillmann HL, et al
   Reply to: "Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients"
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
7. WILSON GK , Brimacombe CL, Rowe IA, Reynolds GM, et al
   A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration.
   J Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SALMON D , Bani-Sadr F, Loko MA, Stitou H, et al
   Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-coinfected patients: Results from ANRS CO13 HEPAVIH.
   J Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ROCCO A , de Nucci G, Valente G, Compare D, et al
   (13)C-Aminopyrine Breath Test Accurately Predicts Long-Term Outcome of Chronic Hepatitis C.
   J Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. NEUKAM K , Camacho A, Lopez-Biedma A, Rallon N, et al
    Prediction of response to pegylated interferon plus ribavirin in HIV/ hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations and HCV-RNA load.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. NISCHALKE HD , Berger C, Luda C, Muller T, et al
    The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian Patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. STICKEL F , Trepo E, Moreno C, Hampe J, et al
    Reply to: "Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C".
    J Hepatol. 2011;55:1471-2.
    PubMed     Text format     Related articles   
    
    
    
    
13. VALENTI L , Colombo M, Fargion S
    Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.
    J Hepatol. 2011;55:1470-1.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
14. FORTON DM
    Hepatitis C treatment - Clearing the mind.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
15. HOWELL CD , Gorden A, Ryan KA, Thompson AJ, et al
    Single Nucleotide Polymorphism Upstream of Interleukin 28B Associated with Phase 1 and Phase 2 of Early Viral Kinetics in Patients Infected with HCV Genotype 1.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. BYRNES V , Miller A, Lowry D, Hill E, et al
    Effects of Anti-Viral Therapy and HCV Clearance on Cerebral Metabolism and Cognition.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KUROSAKI M , Hiramatsu N, Sakamoto M, Suzuki Y, et al
    Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SOGA T , Sugimoto M, Honma M, Mori M, et al
    Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    J Hepatol. 2011;55:896-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
19. SAMONAKIS DN , Germani G, Burroughs AK
    Immunosuppression and HCV Recurrence after Liver Transplantation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. HOSHIDA Y , Fuchs BC, Tanabe KK
    Genomic risk of hepatitis C-related hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. ASSELAH T , De Muynck S, Broet P, Masliah-Planchon J, et al
    IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. NAHON P , Sutton A, Rufat P, Charnaux N, et al
    A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
23. POYNARD T , de Ledinghen V, Zarski JP, Stanciu C, et al
    Relative performances of FibroTest, Fibroscan and biopsy for assessing the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PATRIZIA CARRIERI M , Cohen J, Salmon-Ceron D, Winnock M, et al
    Coffee consumption and reduced self-reported side-effects in HIV-HCV co-infected patients during PEG-IFN and Ribavirin treatment: results from ANRS CO13 HEPAVIH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. ZHAO H , Lin W, Kumthip K, Cheng D, et al
    A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CACOUB P , Bourliere M, Lubbe J, Dupin N, et al
    Dermatological side effects of hepatitis c and its treatment: Patient management in the era of direct-acting antivirals.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ASSELAH T
    Realize the advance in HCV treatment, but remain cautious.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. JOUAN L , Chatel-Chaix L, Melancon P, Rodrigue-Gervais IG, et al
    Targeted impairment of innate antiviral responses in liver of chronic Hepatitis C patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KUMADA H , Toyota J, Okanoue T, Chayama K, et al
    Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. DUARTE-ROJO A , Heathcote EJ, Feld JJ
    'Easy to treat' genotypes were not created equal: can rapid virological response (RVR) level the playing field?
    J Hepatol. 2011;55:466-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
31. JILG N , Chung RT
    Adding to the Toolbox: Receptor Tyrosine Kinases as Potential Targets in the Treatment of Hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. AGHEMO A , Colombo M
    Peginterferon Maintenance Therapy in Patients with Advanced Hepatitis C to Prevent Hepatocellular Carcinoma: The Plot Thickens.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. INGILIZ P , Valantin MA, Petrosi P, Finzi L, et al
    Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZARSKI JP , Sturm N, Guechot J, Paris A, et al
    Comparison of 9 blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. KRAMER JR , Kanwal F, Richardson P, Mei M, et al
    Gaps in the Achievement of Effectiveness of HCV Treatment in National VA Practice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LAN CL , Guillygomarc'h A, Danielou H, Dreau GL, et al
    A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. PRATI GM , Aghemo A, Rumi MG, D'Ambrosio R, et al
    Hyporesponsiveness to pegifnalpha2b plus ribavirin in patients with hepatitis C-related advanced fibrosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. FRIEDMAN SL
    Focus.
    J Hepatol. 2011;55:1-2.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
39. ESTRABAUD E , De Muynck S, Asselah T
    Activation of Unfolded Protein Response and autophagy during HCV infection modulates innate immune response.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ASSELAH T
    A sprint to increase response to HCV treatment: expectancies but caution.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SHIMADA M , Yoshida S, Masuzaki R, Schuppan D, et al
    Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
42. BASSENDINE MF , Sheridan DA, Felmlee DJ, Bridge SH, et al
    HCV and the hepatic lipid pathway as a potential treatment target.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. SHOUVAL D
    Focus.
    J Hepatol. 2011;54:1085-6.
    PubMed     Text format     Related articles   
    
    
    
    
44. ABE H , Hayes CN, Ochi H, Maekawa T, et al
    IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
    J Hepatol. 2011;54:1094-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
45. THOMPSON AJ , Clark PJ, Singh A, Ge D, et al
    Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. DELANG L , Vliegen I, Leyssen P, Neyts J, et al
    In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. HEZODE C
    Oral combination therapy: Future hepatitis C virus treatment?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. HUANG CF , Huang JF, Yang JF, Hsieh MY, et al
    Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ROBINET E , Baumert TF
    A first step towards a mouse model for hepatitis C virus infection containing a human immune system.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. JAFFERBHOY H , Miller MH, El Wahed Z, Dillon JF, et al
    Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. KUROSAKI M , Izumi N
    Reply to: "Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR"
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
52. GAMBARIN-GELWAN M , Jacobson IM
    Chronic hepatitis C genotype 2 and 3: Are we ready for personalized medicine?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
53. TILLMANN HL , Patel K, Muir AJ, Guy CD, et al
    Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. URBANUS AT , van de Laar TJ, van den Hoek A, Zuure FR, et al
    Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. DELTENRE P , Louvet A, Lemoine M, Mourad A, et al
    Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FOX AN , Terrault NA
    Individualizing hepatitis B infection prophylaxis in liver transplant recipients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
57. SHOUVAL D
    Focus.
    J Hepatol. 2011;54:597-8.
    PubMed     Text format     Related articles   
    
    
    
    
58. BEGRICHE K , Massart J, Robin MA, Borgne-Sanchez A, et al
    Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
    J Hepatol. 2011;54:773-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MALHI H , Kaufman RJ
    Endoplasmic reticulum stress in liver disease.
    J Hepatol. 2011;54:795-809.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
60. LANGE CM , Zeuzem S
    IL28B single nucleotide polymorphisms in the treatment of hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LOHSE AW
    Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopy.
    J Hepatol. 2011;54:584-5.
    PubMed     Text format     Related articles   
    
    
    
    
62. THOMPSON MD , Dar MJ, Monga SP
    Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of beta-catenin.
    J Hepatol. 2011;54:506-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
63. CRAXI A
    EASL Clinical Practice Guidelines: Management of hepatitis C virus infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
64. BOCHUD PY , Bibert S, Negro F, Haagmans B, et al
    IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. DELTENRE P , Corouge M, Canva V, Castel H, et al
    Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GANE EJ , Rouzier R, Stedman C, Wiercinska-Drapalo A, et al
    Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN alpha-2a/RBV in hepatitis C patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. GOLDWASSER J , Cohen PY, Lin W, Kitsberg D, et al
    Naringenin Inhibits the Assembly and Long-Term Production of Infectious Hepatitis C Virus Particles Through a PPAR-Mediated Mechanism.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. LANGE CM , Bojunga J, Badenhoop K, Zeuzem S, et al
    Reply to the letter to the Editor of Bitetto et al. (JHEPAT-D-11-00152), entitled "vitamin D deficiency and HCV chronic infection: what comes first?"
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
69. BITETTO D , Fabris C, Falleti E, Toniutto P, et al
    Vitamin D deficiency and HCV chronic infection: what comes first?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
70. RYAN JD , Crowe J
    Hepatocyte iron accumulation: A new string to ribavirin's antiviral bow?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
71. EL-MAOUCHE D , Mehta SH, Sutcliffe C, Higgins Y, et al
    Controlled HIV Viral Replication, Not Liver Disease Severity Associated with Low Bone Mineral Density in HIV/HCV Co-Infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. JAY C , Skaro A, Ladner D, Wang E, et al
    A Comprehensive Risk Assessment of Mortality Following Donation after Cardiac Death Liver Transplant - An Analysis of the National Registry.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. TERRIER B , Carrat F, Geri G, Pol S, et al
    Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. WASMUTH HE , Trautwein C
    Prediction of fibrosis progression in hepatitis C infection: Are genetics ready for clinical use?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
75. REITER J , Perez-Vilaro G, Scheller N, Mina LB, et al
    Hepatitis C virus RNA recombination in cell culture.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. LANG T , Lo C, Skinner N, Locarnini S, et al
    The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. MULLER T , Buch S, Berg T, Hampe J, et al
    Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
78. DULTZ G , Kronenberger B, Azizi A, Mihm U, et al
    Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. COMPARCOLA D , Nobili V, Balsano C, Alisi A, et al
    Effect of the treatment with polynsatured fatty acids on hcv- or diet-induced fatty liver.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
80. HALFON P , Locarnini S
    Hepatitis C virus Resistance to Protease Inhibitors.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. LOPEZ-LABRADOR FX , Berenguer M
    Genomic medicine reaches HCV-related liver transplantation: hopes and clinical and Public Health implications.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
82. BERZSENYI MD , Woollard DJ, McLean CA, Preiss S, et al
    Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. ZEREMSKI M , Hooker G, Shu MA, Winkelstein E, et al
    Induction of CXCR3- and CCR5-associated Chemokines during Acute Hepatitis C Virus Infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. WONG GL , Wong VW, Chan HL
    Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
85. LENCI I , Tisone G, Di Paolo D, Marcuccilli F, et al
    Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver Transplanted for HBV-Related Cirrhosis at Low Risk of HBV Recurrence.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. VALLET-PICHARD A , Fontaine H, Mallet V, Pol S, et al
    Viral hepatitis in solid organ transplantation other than liver.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. HERKEL J , Carambia A
    Let it B in viral hepatitis?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
88. MANNS M , Zeuzem S, Sood A, Lurie Y, et al
    Reduced Dose and Duration of Peginterferon alfa-2b and Weight-Based Ribavirin in Patients With Genotype 2 and 3 Chronic Hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. TORRESI J , Johnson D, Wedemeyer H
    Progress in the development of preventative and therapeutic vaccines for hepatitis C virus.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. NATTERMANN J
    NK cells in acute hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
91. SIKORSKA K , Stalke P, Bielawski KP
    Is there any Association between HCV Multiplication 0nd Iron Induced Liver Injury in Chronic Hepatitis C?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
92. FILLEBEEN C , Pantopoulos K
    Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
93. CAI T , Dufour JF, Muellhaupt B, Gerlach T, et al
    Viral Genotype-Specific Role of PNPLA3, PPARG, MTTP and IL28B in Hepatitis C Virus-Associated Steatosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. FUSCO DN , Chung RT
    New Protease Inhibitors for HCV - Help is on the Way.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
95. TAKANO T , Tsukiyama-Kohara K, Hayashi M, Hirata Y, et al
    Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. ALTER G , Jost S, Rihn S, Reyor LL, et al
    Reduced frequencies of NKp30+NKp46+, CD161+ and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. ASSELAH T
    NS5A inhibitors: a new breakthrough for the treatment of chronic hepatitis C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. GUEVARA M , Baccaro ME, Gomez-Anson B, Frisoni G, et al
    Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. ZHANG L , Jilg N, Shao RX, Lin W, et al
    IL28B inhibits Hepatitis C virus replication through the JAK-STAT pathway.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. LANGE CM , Moradpour D, Doehring A, Lehr HA, et al
     Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. OZE T , Hiramatsu N, Yakushijin T, Mochizuki K, et al
     Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. FORESTIER N , Larrey D, Guyader D, Marcellin P, et al
     Treatment of Chronic Hepatitis C Patients with the NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) Leads to Robust Reductions in Viral RNA: A Phase 1b Multiple Ascending Dose Study.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. MARTIN NK , Vickerman P, Foster GR, Hutchinson SJ, et al
     Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. ALISI A , Ghidinelli M, Zerbini A, Missale G, et al
     Hepatitis c virus and alcohol: same mitotic targets but different signaling pathways.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. SCHERZER TM , Hofer H, Staettermayer AF, Rutter K, et al
     Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. COSTENTIN CE , Roudot-Thoraval F, Zafrani ES, Medkour F, et al
     Association Of Caffeine Intake and Histological Features of Chronic Hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. LANGE CM , Bojunga J, Ramos-Lopez E, Wagner MV, et al
     Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. FERAY C
     Liver transplantation as a model to better understand the cell entry of hepatitis C virus.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. KHATTAB MA , Ferenci P, Hadziyannis SJ, Colombo M, et al
     Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
110. GONZALEZ-CARMONA MA , Vogt A, Heinicke T, Quasdorff M, et al
     Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. ABE H , Imamura M, Hiraga N, Tsuge M, et al
     ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. SELZNER N , Guindi M, Renner EL, Berenguer M, et al
     Immune-mediated complications of the graft in interferon-treated Hepatitis C positive Liver transplant recipients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. DRUMRIGHT LN , Hagan H, Thomas DL, Latka MH, et al
     Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. TREPO E , Potthoff A, Pradat P, Bakshi R, et al
     Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. TABATABAEI SV , Alavian SM, Keshvari M, Behnava B, et al
     Low Dose Ribavirin for Treatment of HCV Infected Thalassemia Major Patients; New Indications for Combination Therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. FRIED MW , Hadziyannis SJ, Shiffman ML, Messinger D, et al
     Rapid Virological Response Is the Most Important Predictor of Sustained Virological Response Across Genotypes in Patients with Chronic Hepatitis C Virus Infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. GREBELY J , Matthews GV, Hellard M, Shaw D, et al
     Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. OLIVIERO B , Cerino A, Varchetta S, Paudice E, et al
     Enhanced B Cell Differentiation and Reduced Proliferative Capacity in Chronic Hepatitis C and Chronic Hepatitis B Virus Infections.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. PIANA G , Trinquart L, Meskine N, Barrau V, et al
     New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. FUJIMOTO Y , Ochi H, Maekawa T, Abe H, et al
     A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. ZEISEL MB , Fofana I, Fafi-Kremer S, Baumert TF, et al
     Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. MANNS MP , Bourliere M, Benhamou Y, Pol S, et al
     Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. LAGGING M , Alsio S, Hellstrand K, Norkrans G, et al
     Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
124. NOVO E , Busletta C, di Bonzo LV, Povero D, et al
     Intracellular Reactive Oxygen Species Are Required For Directional Migration Of Resident And Bone Marrow-Derived Hepatic Pro-Fibrogenic Cells.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. OHARA E , Hiraga N, Imamura M, Iwao E, et al
     Elimination of Hepatitis C Virus by Short Term NS3-4A and NS5B Inhibitor Combination Therapy in Human Hepatocyte Chimeric Mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. DE JONG YP , Rice CM, Ploss A
     Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
127. BARTH H
     Insights into the role of interferon lambda in hepatitis C virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
128. LANGHANS B , Kupfer B, Braunschweiger I, Arndt S, et al
     Interferon-lambda serum levels in hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. WALTER SR , Thein HH, Amin J, Gidding HF, et al
     Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. BERG T , Biermer M, Neumann U
     Silibinin in hepatitis C related liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
131. BEINHARDT S , Rasoul-Rockenschaub S, Scherzer TM, Ferenci P, et al
     Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
132. MCCAUGHAN GW , Bowen DG
     Pathogenesis of cholestatic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
133. FRAQUELLI M , Rigamonti C, Casazza G, Donato MF, et al
     Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
134. JANG JY , Shao RX, Lin W, Weinberg E, et al
     HIV infection increases HCV-induced hepatocyte apoptosis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. RIEZU-BOJ JI , Larrea E, Aldabe R, Guembe L, et al
     Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. LAMBERT MP , Paliwal A, Vaissiere T, Chemin I, et al
     Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. MIYOSHI H , Moriya K, Tsutsumi T, Shinzawa S, et al
     Pathogenesis of lipid metabolism disorder in hepatitis C: Polyunsaturated fatty acids counteract lipid alterations induced by the core protein.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. SARRAZIN C , Susser S, Doehring A, Lange CM, et al
     Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. KAWAOKA T , Hayes CN, Ohishi W, Ochi H, et al
     Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. KUROSAKI M , Tanaka Y, Nishida N, Sakamoto N, et al
     Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. FABRIS C , Falleti E, Cussigh A, Bitetto D, et al
     IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. POYNARD T , Munteanu M, Colombo M, Bruix J, et al
     FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC(3) program.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. HUANG JF , Yu ML, Huang CF, Chiu CF, et al
     The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. DIMOVA RB , Talal AH
     Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa.
     J Hepatol. 2010;53:418-20.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
145. GARCIA-MONZON C , Lo Iacono O, Mayoral R, Gonzalez-Rodriguez A, et al
     Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. MUELLER S
     Increased iron in HCV infection: Collateral damage or antiviral defense?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
147. SYDER AJ , Lee H, Zeisel MB, Grove J, et al
     Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. VACHON ML , Factor SH, Branch AD, Fiel MI, et al
     Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-alpha-2a and ribavirin in HIV/HCV co-infected patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. GAIA S , Carenzi S, Barilli AL, Bugianesi E, et al
     Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. DEGOS F , Perez P, Roche B, Mahmoudi A, et al
     Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study).
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. FAFI-KREMER S , Habersetzer F, Baumert TF
     Hepatitis C virus entry and glucocorticosteroids.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
152. MANGIA A , Bandiera F, Montalto G, Mottola L, et al
     Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. LANGE CM , Roomp K, Dragan A, Nattermann J, et al
     HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. FILLEBEEN C , Pantopoulos K
     Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. RATZIU V
     Serum fibrosis markers: death by validation or a leap of faith?
     J Hepatol. 2010;53:222-4.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
156. VON DEM BUSSCHE A , Machida R, Li K, Loevinsohn G, et al
     Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. CARRION JA , Navasa M, Forns X
     Retransplantation in patients with hepatitis C recurrence after liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. PELLETIER S , Drouin C, Bedard N, Khakoo SI, et al
     Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. HONDA M , Nakamura M, Tateno M, Sakai A, et al
     Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. NKONTCHOU G , Bastard JP, Ziol M, Aout M, et al
     Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. GOETZ M , Deris I, Vieth M, Murr E, et al
     Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth.
     J Hepatol. 2010;53:84-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
162. BARNABA V
     Hepatitis C virus infection: A "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. GOWANS EJ , Roberts S, Jones K, Dinatale I, et al
     A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. FOERESTER K , Helmy A, Zhu Y, Khattar R, et al
     The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. CHENG WS , Roberts SK, McCaughan G, Sievert W, et al
     Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. ROOMER R , Hansen BE, Janssen HL, de Knegt RJ, et al
     Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. BARTENSCHLAGER R , Cosset FL, Lohmann V
     Hepatitis C virus replication cycle.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     May 2010
168. ABE H , Ochi H, Maekawa T, Hayes CN, et al
     A common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. SUTTI S , Vidali M, Mombello C, Sartori M, et al
     Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: Possible role for molecular mimicry.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. VANWOLLEGHEM T , Libbrecht L, Hansen BE, Desombere I, et al
     Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. ROBINET E , Baumert TF
     Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
172. DAHARI H , Affonso de Araujo ES, Haagmans BL, Layden TJ, et al
     Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: Implications for treatment outcomes.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. SETO WK , Lai CL, Fung J, Hung I, et al
     Natural history of chronic hepatitis C: Genotype 1 versus genotype 6.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. MIYAGI T , Takehara T, Nishio K, Shimizu S, et al
     Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. JOHN-BAPTISTE A , Krahn M, Heathcote J, Laporte A, et al
     The natural history of hepatitis C infection acquired through injection drug use: Meta-analysis and meta-regression.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
176. ZEISEL MB , Turek M, Baumert TF
     Getting closer to the patient: Upgrade of hepatitis C virus infection in primary human hepatocytes.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. CACOUB P , Halfon P, Rosenthal E, Bailly F, et al
     Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. HOARE M , Gelson WT, Das A, Fletcher JM, et al
     CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. STURM N , Thelu MA, Camous X, Dimitrov G, et al
     Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. CALES P , Halfon P, Batisse D, Carrat F, et al
     Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. SHOUVAL D
     Hospital related morbidity from chronic hepatitis C virus (HCV) infection in Australia and mortality from HCV infection in a population cohort in Denmark: Two complementary studies relevant to counseling patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
182. GIDDING HF , Amin J, Dore GJ, Ward K, et al
     Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. CHATTERJI U , Lim P, Bobardt MD, Wieland S, et al
     HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
184. WATT KD , Charlton MR
     Metabolic syndrome and liver transplantation: A review and guide to management.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. DHILLON N , Walsh L, Kruger B, Ward SC, et al
     A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. OMLAND LH , Krarup H, Jepsen P, Georgsen J, et al
     Mortality in patients with chronic and cleared hepatitis C viral infection: A nationwide cohort study.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. MUELLER M , Spangenberg HC, Kersting N, Altay T, et al
     Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. SHEN YC , Hsu C, Chen LT, Cheng CC, et al
     Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. SHOUVAL D
     The impact of ribavirin treatment on spermatogenesis in patients with chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
190. PAWLOTSKY JM
     More sensitive hepatitis C virus RNA detection: What for?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
191. HOFER H , Donnerer J, Sator K, Staufer K, et al
     Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. SARRAZIN C , Shiffman ML, Hadziyannis SJ, Lin A, et al
     Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. SOKAL EM , Bourgois A, Stephenne X, Silveira T, et al
     Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. NEUMANN UP , Biermer M, Eurich D, Neuhaus P, et al
     Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
195. CLEMENT S , Pascarella S, Conzelmann S, Gonelle-Gispert C, et al
     The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. CARDOSO AC , Moucari R, Figueiredo-Mendes C, Ripault MP, et al
     Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. FUKUHARA T , Taketomi A, Okano S, Ikegami T, et al
     Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. BEAUVILLAIN C , Meloni F, Sirard JC, Blanchard S, et al
     The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. BHOORI S , Toffanin S, Sposito C, Germini A, et al
     Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
200. ROCHE B , Samuel D
     Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
201. FORNS X , Bruix J
     Treating hepatitis C in patients with cirrhosis: The effort is worth it.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
202. WIRTH S , Ribes-Koninckx C, Calzado MA, Bortolotti F, et al
     High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. SHOUVAL D
     Focus.
     J Hepatol. 2010;52:145-6.
     PubMed     Text format     Related articles   
     
     
     
     January 2010
204. ASSELAH T
     Genetic polymorphism and response to treatment in chronic hepatitis C: The future of personalized medicine.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. ALISI A , Comparcola D, Nobili V
     Treatment of chronic hepatitis C in children: Is it necessary and, if so, in whom?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
206. BENGSCH B , Thimme R
     Ribavirin ante portas: Uptake transporters into hepatocytes dissected.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
207. SAMUEL D
     Focus.
     J Hepatol. 2010;52:3-4.
     PubMed     Text format     Related articles   
     
     
     
     December 2009
208. CLAASSEN MA , de Knegt RJ, Tilanus HW, Janssen HL, et al
     Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. LISMAN T , Bakhtiari K, Pereboom IT, Hendriks HG, et al
     Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: